SUMMARY Six cases of primary cerebral lymphoma were immunophenotyped and analysed by Southern blotting to determine the clonality and lineage of these neoplasms. Molecular analysis showed that they were of B cell origin, and the rearrangement of both heavy and light chain immunoglobulins in malignant cells showed that they were monoclonal populations of mature B cells.
Primary cerebral lymphoma is relatively rare, comprising between 0-3 and 1-5% of all intracranial tumours.' Until recently, several diagnostic labels were applied to this tumour, including reticulum cell sarcoma and microglioma. The precise cell of origin of primary cerebral lymphoma is a subject of controversy, although an association between these neoplasms and non-Hodgkin's lymphoma has been acknowledged.2 The ability to distinguish between primary lymphoma of the central nervous system (CNS) and other malignant cerebral tumours has clinical consequences, as many cerebral lymphomas are radiosensitive. 3 The use of monoclonal antibodies has facilitated such differential diagnosis in certain cases. 4 An immunohistochemical study of 20 cerebral lymphomas showed binding by the monoclonal antibody B1, which recognises the antigen CD20, indicating that they were B cell malignancies. 4 The presence of reactive T cells in cerebral lymphomas, however, may lead to difficulty in diagnosis if the immunohistochemical data are not clear.
The use of molecular techniques to determine the lineage and clonality of lymphoproliferative conditions has become more widespread in the past few years due to the availability of recombinant DNA probes encoding the immunoglobulin and T cell receptor genes.5 These genes are organised in the genome in a segmental fashion and undergo somatic rearrangement during commitment to the B or T cell Accepted for publication 14 September 1987 lineage.6 Each lymphocyte undergoes a specific rearrangement of its immunoglobulin or T cell receptor genes, which is unique to the cell. Consequently, if a particular cell undergoes a clonal expansion, the whole clone can be identified by its genetic configuration using the Southern blot technique. The ability to distinguish between monoclonal and reactive proliferations of lymphocytes is of considerable benefit in the diagnosis of lymphoma.
We analysed six cases of primary cerebral lymphomas by immunophenotyping and by Southern blot analysis to determine the clonality and lineage of these neoplasms.
Material and methods
Cases were diagnosed as primary cerebral lymphoma on the basis of histological and immunohistochemical studies. DNA generated by DNA polymorphisms as they were detected in all three restriction digests analysed for each case. The germline fragments which hybridised to the Jh probe originated from the normal cells in the biopsy specimen or, in case B7, the non-rearranged Jh allele in the neoplastic clone. In all cases, with the exception of B7, both alleles of the immunoglobulin heavy chain gene had undergone somatic recombination. The intensities of the non-germline bands on the autoradiographs indicated that the neoplastic clones comprised a high proportion of the cell populations examined.
Immunohistochemical study of these cases did not include an analysis of the immunoglobulin light chains Immunophenotyping and genetic analysis confirmed that lymphoma was present which proved to be radiosensitive in these cases. Similarly, genetic and immunological analysis of case B7 showed the presence of B cell lymphoma rather than an undifferentiated metastasis. The correct diagnosis of this case was made retrospectively (on frozen tissue) as part of an immunohistological review of undifferentiated tumours. The patient had not received radiotherapy and died two months after biopsy. This contrasts with the relatively longer survivals of those patients who had received radiotherapy (table 5) .
The characterisation of the genetic configuration of the immunoglobulin genes in these lymphomas would be of benefit in the event of a patient developing a further tumour. If the new neoplasm possessed a genetic configuration identical with that of the original lymphoma, it would indicate the re-emergence of the original B cell clone.
In conclusion, we have shown that the primary cerebral tumours studied in this series by immun-132 Smith, Garson, Bourne, Kemshead, Coakham ological and genetic analysis were B cell malignancies, arrested at the mature end of the B cell differentiation pathway. These methods provide the neuropathologist with information which may have important clinical implications.
